title: Improving drug manufacturing with process analytical technology.
abstract: Within the process analytical technology (PAT) framework, as presented in the US Food and Drug Administration guidelines, the aim is to design, develop and operate processes consistently to ensure a pre-defined level of quality at the end of the manufacturing process. Three PAT implementation scenarios can be envisaged. Firstly, PAT could be used in its most modest version (in an almost non-PAT manner) to simply replace an existing quality control protocol (eg, using near-infrared spectroscopy for an in-process quality control, such as moisture content). Secondly, the use of in-process monitoring and process analysis could be integrated to enhance process understanding and operation for an existing industrial process. Thirdly, PAT could be used extensively and exclusively throughout development, scale-up and full-scale production of a new product and process. Although the first type of implementations are well known, reports of the second and third types remain scarce. Herein, results obtained from PAT implementations of the second and third types are described for two industrial processes for preparing bulk active pharmaceutical ingredients, demonstrating the benefits in terms of increased process understanding and process control.
authors.affiliation: CIPAN SA, Castanheira do Ribatejo, Portugal.
authors.forename: Licinia O
authors.initials: LO
authors.lastname: Rodrigues
authors.forename: Teresa P
authors.initials: TP
authors.lastname: Alves
authors.forename: Joaquim P
authors.initials: JP
authors.lastname: Cardoso
authors.forename: José C
authors.initials: JC
authors.lastname: Menezes
mesh_terms: D002138:Calibration; D002626:Chemistry, Pharmaceutical / Q000379:methods / Q000592:standards*; D003460:Crystallization; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards; D005285:Fermentation; D006801:Humans; D006865:Hydrogenation; D007880:Legislation, Drug; D015999:Multivariate Analysis; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000737:chemistry / Q000302:isolation & purification; D025341:Principal Component Analysis; D011786:Quality Control; D015203:Reproducibility of Results; D013055:Spectrophotometry, Infrared; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards
chemical_list: D004364:Pharmaceutical Preparations